WHO

News
Bacteria-generic-2

WHO criticises lack of big pharma antibiotic R&D

Big pharma still continues to look upon antibiotic resistance as somebody else’s problem, the World Health Organization has warned, in a dismal update outlining the lack of private investme

Partner Content
iStock 640091470
Partner Content

How to fix your adherence problem

Typical patient support programs fail to improve adherence - and it’s costing the pharma industry billions. Here’s how to do a better job.